USFDA conducts GMP inspection at Indoco Remedies’ Solid Oral Formulation Facility in Goa

23 Jan 2023 Evaluate

The United States Food and Drug Administration (USFDA) have conducted GMP inspection at Indoco Remedies’ Solid Oral Formulation Facility (Plant 1) in Goa. The inspection was conducted from January 16, 2023 to January 20, 2023.

The USFDA has issued Form 483 with 9 observations, which will be addressed within stipulated time. The company is committed to maintain compliances across all our facilities with cGMP quality standards at all times.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

251.25 -0.65 (-0.26%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×